Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 752,600 shares, a growth of 20.7% from the October 15th total of 623,600 shares. Based on an average daily volume of 145,200 shares, the short-interest ratio is currently 5.2 days. Currently, 2.3% of the company's shares are short sold.
Wall Street Analyst Weigh In
Several equities analysts have commented on BIOX shares. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a "strong-buy" rating in a research note on Friday, July 19th. Oppenheimer dropped their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating for the company in a research note on Monday, October 21st. Roth Mkm dropped their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, September 11th. Canaccord Genuity Group dropped their price target on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating for the company in a research note on Wednesday. Finally, Lake Street Capital dropped their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, September 11th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Buy" and an average target price of $12.13.
Check Out Our Latest Report on BIOX
Bioceres Crop Solutions Stock Down 3.9 %
Shares of BIOX stock traded down $0.25 on Friday, reaching $6.17. 232,760 shares of the stock were exchanged, compared to its average volume of 90,121. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37. The business's 50 day moving average price is $7.58 and its 200 day moving average price is $9.80. The company has a market capitalization of $387.78 million, a price-to-earnings ratio of 321.16 and a beta of 0.49. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last issued its earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). The firm had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter in the previous year, the firm posted ($0.07) EPS. As a group, sell-side analysts expect that Bioceres Crop Solutions will post 0.33 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Bioceres Crop Solutions
A number of institutional investors and hedge funds have recently bought and sold shares of BIOX. Fourth Sail Capital LP lifted its position in Bioceres Crop Solutions by 61.6% in the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock valued at $24,957,000 after acquiring an additional 1,209,277 shares during the last quarter. Long Focus Capital Management LLC raised its holdings in shares of Bioceres Crop Solutions by 19.9% in the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock valued at $3,145,000 after buying an additional 46,647 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in shares of Bioceres Crop Solutions in the second quarter valued at about $472,000. Ping Capital Management Inc. purchased a new stake in shares of Bioceres Crop Solutions in the second quarter valued at about $448,000. Finally, Lazard Asset Management LLC purchased a new stake in shares of Bioceres Crop Solutions in the first quarter valued at about $212,000. 17.68% of the stock is owned by hedge funds and other institutional investors.
About Bioceres Crop Solutions
(
Get Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.